Max Planck
The company plans to use Planegg, Germany-based OmicEra's mass spectrometry-based proteomics technologies for cancer biomarker discovery.
Improved Pool Testing Methods Could Enable COVID-19 Screening as Pandemic Continues
While new ways to carry out pool testing for SARS-CoV-2 abound, questions remain about sensitivity issues and the regulation of such tests.